Loading...

PE anti-mouse CD4 Antibody PE anti-mouse CD4 Antibody

Pricing & Availability
Clone
GK1.5 (See other available formats)
Regulatory Status
RUO
Other Names
L3T4, T4
Isotype
Rat IgG2b, κ
Ave. Rating
Submit a Review
Product Citations
publications
1_GK1dot5_PE_021706
C57BL/6 mouse splenocytes were stained with CD4 (clone GK1.5) PE (filled histogram) or rat IgG2b, κ PE isotype control (open histogram).
  • 1_GK1dot5_PE_021706
    C57BL/6 mouse splenocytes were stained with CD4 (clone GK1.5) PE (filled histogram) or rat IgG2b, κ PE isotype control (open histogram).
  • 2_GK15_PE_CD4_Antibody_2_040122
    C57BL/6 mouse splenocytes were stained with CD4 (clone GK1.5) PE (solid line) or rat IgG2b, κ PE isotype control (dashed line).
Compare all formats See PE spectral data
Cat # Size Price Quantity Check Availability Save
100407 50 µg SEK210
Check Availability


Need larger quantities of this item?
Request Bulk Quote
100408 200 µg SEK605
Check Availability


Need larger quantities of this item?
Request Bulk Quote
Description

CD4 is a 55 kD protein also known as L3T4 or T4. It is a member of the Ig superfamily, primarily expressed on most thymocytes, a subset of T cells, and weakly on macrophages and dendritic cells. It acts as a coreceptor with the TCR during T cell activation and thymic differentiation by binding MHC class II and associating with the protein tyrosin kinase, lck.

Product Details
Technical Data Sheet (pdf)

Product Details

Verified Reactivity
Mouse
Antibody Type
Monoclonal
Host Species
Rat
Immunogen
Mouse CTL clone V4
Formulation
Phosphate-buffered solution, pH 7.2, containing 0.09% sodium azide.
Preparation
The antibody was purified by affinity chromatography, and conjugated with PE under optimal conditions.
Concentration
0.2 mg/ml
Storage & Handling
The CD4 antibody solution should be stored undiluted between 2°C and 8°C, and protected from prolonged exposure to light. Do not freeze.
Application

FC - Quality tested
Recommended Usage

Each lot of this antibody is quality control tested by immunofluorescent staining with flow cytometric analysis. For flow cytometric staining, the suggested use of this reagent is ≤0.25 µg per million cells in 100 µl volume. It is recommended that the reagent be titrated for optimal performance for each application.

Excitation Laser
Blue Laser (488 nm)
Green Laser (532 nm)/Yellow-Green Laser (561 nm)
Application Notes

Additional reported applications (for the relevant formats) include: blocking of CD4+ T cell activation1,4,11, thymocyte costimulation3, in vitro and in vivo depletion2,5-8, blocking of egg-sperm cell adhesion1,4, immunohistochemical staining of acetone-fixed frozen sections9,10, immunoprecipitation1,2, and spatial biology (IBEX)12,13. The GK1.5 antibody is able to block CD4 mediated cell adhesion and T cell activation. Binding of GK1.5 antibody to CD4 T cells can be blocked by RM4-5 antibody, but not RM4-4 antibody. For in vivo studies or highly sensitive assays, we recommend Ultra-LEAF™ purified antibody (Cat. No. 100442) with a lower endotoxin limit than standard LEAF™ purified antibodies (Endotoxin < 0.01 EU/µg).

Application References
  1. Dialynas DP, et al. 1983. J. Immunol. 131:2445. (Block, IP)
  2. Dialynas DP, et al. 1983. Immunol. Rev. 74:29. (IP, Deplete)
  3. Wu L, et al. 1991. J. Exp. Med. 174:1617. (Costim)
  4. Godfrey DI, et al. 1994. J. Immunol. 152:4783. (Block)
  5. Gavett SH, et al. 1994. Am. J. Respir. Cell. Mol. Biol. 10:587. (Deplete)
  6. Schuyler M, et al. 1994. Am. J. Respir. Crit. Care Med. 149:1286. (Deplete)
  7. Ghobrial RR, et al. 1989. Clin. Immunol. Immunopathol. 52:486. (Deplete)
  8. Israelski DM, et al. 1989. J. Immunol. 142:954. (Deplete)
  9. Zheng B, et al. 1996. J. Exp. Med. 184:1083. (IHC)
  10. Frei K, et al. 1997. J. Exp. Med. 185:2177. (IHC)
  11. Felix NJ, et al. 2007. Nat. Immunol. 8:388. (Block)
  12. Radtke AJ, et al. 2020. Proc Natl Acad Sci U S A. 117:33455-65. (SB) PubMed
  13. Radtke AJ, et al. 2022. Nat Protoc. 17:378-401. (SB) PubMed
Product Citations
  1. Zveik O, et al. 2022. Glia. 70:1191. PubMed
  2. Yue Y, et al. 2022. Nat Biomed Eng. 6:898. PubMed
  3. Zhou H, et al. 2022. EMBO Rep. 23:e53791. PubMed
  4. Grebinoski S, et al. 2022. Nat Immunol. 23:868. PubMed
  5. Merana GR, et al. 2022. Cell Rep. 39:110891. PubMed
  6. Guo X, et al. 2022. Invest Ophthalmol Vis Sci. 63:12. PubMed
  7. Tessaro FHG, et al. 2022. Cell Rep. 39:110977. PubMed
  8. Shen CY, et al. 2022. Pharmaceutics. 14: . PubMed
  9. Millar FR, et al. 2022. Cell Rep. 41:111596. PubMed
  10. Zhu J, et al. 2022. Nat Commun. 13:7466. PubMed
  11. Shi C, et al. 2023. Nat Nanotechnol. 18:86. PubMed
  12. Yu J, et al. 2022. Nat Commun. 13:7903. PubMed
  13. Zhao X, et al. 2022. STAR Protoc. 3:101859. PubMed
  14. Choi H, et al. 2023. J Nanobiotechnology. 21:5. PubMed
  15. Wang L, et al. 2022. Nutrients. 15: . PubMed
  16. Glaubitz J, et al. 2023. Gut. :. PubMed
  17. Zhao M, et al. 2023. J Nanobiotechnology. 21:50. PubMed
  18. Wang L, et al. 2023. Oxid Med Cell Longev. 2023:6480848. PubMed
  19. Kodali S, et al. 2022. J Immunol. 208:1085. PubMed
  20. McCafferty S, et al. 2022. Mol Ther. 30:2968. PubMed
  21. Puth S, et al. 2022. Biomaterials. 286:121542. PubMed
  22. Lin J, et al. 2022. Adv Sci (Weinh). 9:e2202633. PubMed
  23. Zhao Q, et al. 2023. Signal Transduct Target Ther. 8:40. PubMed
  24. Wang F, et al. 2023. Int J Mol Sci. 24:. PubMed
  25. Wang JX, et al. 2023. JCI Insight. 8:. PubMed
  26. Tan X, et al. 2023. Adv Sci (Weinh). 10:e2206768. PubMed
  27. Fu S, et al. 2023. Nat Commun. 14:2248. PubMed
  28. Kaltenbach L, et al. 2023. Nat Immunol. 24:915. PubMed
  29. Wu N, et al. 2023. Front Bioeng Biotechnol. 11:1173381. PubMed
  30. Ji Y, et al. 2023. Nat Cell Biol. 25:726. PubMed
  31. Guo X, et al. 2023. Mol Immunol. 160:32. PubMed
  32. Kawai H, et al. 2021. Asian Pac J Allergy Immunol. :. PubMed
  33. Tan L, et al. 2022. Aging Dis. 13:1562. PubMed
  34. Palacios-Arreola M, et al. 2017. Sci Rep. 10.1038/s41598-017-10135-1. PubMed
  35. Man SM et al. 2016. Cell. 167(2):382-396 . PubMed
  36. Jiang W, et al. 2017. Sci Rep. 7:6501. PubMed
  37. Xu X, et al. 2020. Chin Med. 15:33. PubMed
  38. Kisielow J, et al. 2019. Nat Immunol. 1.286111111. PubMed
  39. Ajith A, et al. 2021. Front Immunol. 12:687715. PubMed
  40. Garo LP, et al. 2021. Nat Commun. 12:2419. PubMed
  41. Apte SH, et al. 2020. Clin Transl Immunology. 9:e1209. PubMed
  42. Friess MC, et al. 2022. Cell Rep. 38:110334. PubMed
  43. Xiang G, et al. 2022. Cell Death Dis. 13:451. PubMed
  44. Shibata K, et al. 2022. Nat Commun. 13:6948. PubMed
  45. Feola S, et al. 2022. Front Immunol. 13:826164. PubMed
  46. Zhao X, et al. 2022. Front Mol Biosci. 9:786864. PubMed
  47. Qian Y, et al. 2021. Cell Reports. 36(8):109602. PubMed
  48. Chappaz S, et al. 2021. Cell Reports. 36(3):109430. PubMed
  49. Han X, et al. 2017. Int J Mol Sci. 10.3390/ijms18050942. PubMed
  50. Willinger T, et al. 2014. J Exp Med. 211:685. PubMed
  51. Bauer KM, et al. 2022. JCI Insight. 7:. PubMed
  52. Misumi I et al. 2019. Cell Rep. 27(5):1387-1396 . PubMed
  53. Du Q, et al. 2019. Front Microbiol. 10:2050. PubMed
  54. Zhang L, et al. 2020. Front Oncol. 1.243055556. PubMed
  55. Zhang J, et al. 2021. MedComm (Beijing). 2:256. PubMed
  56. Jiang W, et al. 2021. Oncol Lett. 22:625. PubMed
  57. Greenberg J, et al. 2022. JCI Insight. Online ahead of print. PubMed
  58. Tan X, et al. 2021. Front Oncol. 11:768222. PubMed
  59. Ma C, et al. 2021. Signal Transduct Target Ther. 6:353. PubMed
  60. Fu Y, et al. 2020. Mol Ther. 1214:28. PubMed
  61. Haque M, et al. 2021. STAR Protoc. 2:100264. PubMed
  62. Hao B, et al. 2015. J Exp Med. 212:809. PubMed
  63. Sun CC, et al. 2020. Genome Med. 0.553472222. PubMed
  64. Leech JM, et al. 2020. Cell Host & Microbe. 26(6):795-809.e5.. PubMed
  65. Isoda T et al. 2017. Cell. 171(1):103-119 . PubMed
  66. Glaubitz J, et al. 2022. Nat Commun. 13:4502. PubMed
  67. Liang Z, et al. 2021. J Cell Physiol. 236:4725. PubMed
  68. Chen S et al. 2018. Cell reports. 25(7):1729-1740 . PubMed
  69. Pérez‐Mazliah D et al. 2017. EBioMedicine. 24:216-230 . PubMed
  70. Yuan X, et al. 2019. JCI Insight. 4:e124317. PubMed
  71. Tsuchiya N, et al. 2020. Cell Reports. 29(1):162-175.e9.. PubMed
  72. Guo H, et al. 2022. PLoS Pathog. 18:e1010857. PubMed
  73. Khan IM, et al. 2021. Immunohorizons. 5:703. PubMed
  74. Antunes KH, et al. 2022. Front Immunol. 13:867022. PubMed
  75. Li Y, et al. 2022. Clin Transl Immunology. 11:e1362. PubMed
  76. Li H, et al. 2021. Nat Commun. 12:2773. PubMed
  77. Zhang Z, et al. 2021. Oncoimmunology. 10:1912472. PubMed
  78. Mitchell JE, et al. 2021. Cell Reports. 35(2):108966. PubMed
  79. Han C, et al. 2021. Cell Reports. 34(6):108706. PubMed
  80. Perner C, et al. 2020. Immunity. 53(5):1063-1077.e7. PubMed
  81. Sato K, et al. 2015. PLoS One. 10: 0138291. PubMed
  82. Liu J, et al. 2012. PLoS One. 7:e44044. PubMed
  83. Lercher A, et al. 2019. Immunity. 51:1074. PubMed
  84. He W et al. 2018. Immunity. 49(6):1175-1190 . PubMed
  85. Hillel–Karniel C, et al. 2020. Cell Reports. 30(3):807-819.e4.. PubMed
  86. Collin R, et al. 2014. J Immunol. 193:3503. PubMed
  87. Karki R, et al. 2020. JCI Insight. 5:00. PubMed
  88. Paiva RA, et al. 2021. Cell Reports. 35(2):108967. PubMed
  89. Pereira JL, et al. 2021. Transl Oncol. 14:101125. PubMed
  90. Yang L, et al. 2021. Cell Death Differ. 28:2616. PubMed
  91. Pervaiz N, et al. 2021. Pigment Cell Melanoma Res. 34:918. PubMed
  92. Sodji QH, et al. 2022. Cancer Res Commun. 2:725. PubMed
  93. Li J, et al. 2021. Cell Commun Signal. 19:89. PubMed
  94. Lv F, et al. 2022. iScience. 25:103639. PubMed
  95. Mehta AK, et al. 2021. Nat Cancer. 2:66. PubMed
  96. Liu D et al. 2019. Immunity. 51(1):64-76 . PubMed
  97. Fatkhullina AR et al. 2018. Immunity. 49(5):943-957 . PubMed
  98. Akazawa S, et al. 2021. Diabetologia. 64:878. PubMed
  99. Jie X, et al. 2022. J Immunother Cancer. 10:. PubMed
  100. Yang H, et al. 2022. Nutrients. 14:. PubMed
  101. Hönes J, et al. 2017. Sci Rep. . 10.1038/s41598-017-15866-9. PubMed
  102. Lee JS et al. 2018. Cell. 174(6):1559-1570 . PubMed
  103. Niemann J, et al. 2019. Nat Commun. 10:3236. PubMed
  104. Schadt L, et al. 2020. Cell Reports. 29(5):1236-1248.e7.. PubMed
  105. Aebischer D, et al. 2014. PLoS One. 9:99297. PubMed
  106. Xie Z, et al. 2020. Light Sci Appl. 0.486805556. PubMed
  107. Huang YL, et al. 2021. Commun Biol. 4:229. PubMed
  108. Ren Y, et al. 2022. J Immunother Cancer. 10:. PubMed
  109. Harnett MM, et al. 2022. Front Immunol. 13:953053. PubMed
  110. Shen X, et al. 2021. Front Immunol. 12:710750. PubMed
  111. Zuo W, et al. 2022. Cell Death Discov. 8:257. PubMed
  112. Zeng Q, et al. 2022. Front Immunol. 13:740805. PubMed
  113. Zuo S, et al. 2021. J Immunother Cancer. 9:. PubMed
  114. Chen G, et al. 2021. Sci Adv. 7:eabg5686. PubMed
  115. Yang C, et al. 2013. Proc Natl Acad Sci U S A. 111:109. PubMed
  116. Mirando AC, et al. 2020. Oncoimmunology. 9:1760685. PubMed
  117. Cheng Y, et al. 2020. PLoS Pathog. 16:e1008569. PubMed
  118. Parhi L, et al. 2020. Nat Commun. 2.721527778. PubMed
  119. Bai C, et al. 2020. Mol Ther Oncolytics. 17:9. PubMed
  120. Jing Y, et al. 2020. Sci Adv. 6:eaax9455. PubMed
  121. Dmitrieva‐Posocco O et al. 2019. Immunity. 50(1):166-180 . PubMed
  122. Li W, et al. 2019. Nat Commun. 10:3349. PubMed
  123. Palazon A, et al. 2017. Cancer Cell. . 10.1016/j.ccell.2017.10.003. PubMed
  124. Wu H, et al. 2021. Cell Death Discov. 7:225. PubMed
  125. Colombo M, et al. 2022. iScience. 25:105042. PubMed
  126. Ren W, et al. 2018. Mucosal Immunol. 12:531. PubMed
  127. Cai Y, et al. 2019. Cell Rep. 27:3034. PubMed
  128. Matsuo K, et al. 2018. J Immunol. 200:800. PubMed
  129. Du J, et al. 2018. AMB Express. 8:158. PubMed
  130. Guldner IH, et al. 2020. Cell. 183(5):1234-1248.e25. PubMed
  131. Trefzer A, et al. 2021. Cell Reports. 34(6):108748. PubMed
  132. Kruta M, et al. 2021. Cell Stem Cell. :. PubMed
  133. Liu W, et al. 2021. Cell Death Discov. 7:136. PubMed
  134. Huang Z, et al. 2021. Nat Commun. 12:145. PubMed
  135. Cho K, et al. 2021. iScience. 24:103117. PubMed
  136. Andrade ACDSP, et al. 2021. J Virol. 95:e0127621. PubMed
  137. Ding P, et al. 2022. Bone Res. 10:42. PubMed
  138. Daneshmandi S, et al. 2021. Elife. 10:. PubMed
  139. Liyanage S, et al. 2016. Exp Eye Res. 151:160-70. PubMed
  140. Guo H, et al. 2014. J Leukoc Biol. 96:419. PubMed
  141. Tomay F, et al. 2019. J Transl Med. 17:237. PubMed
  142. Tsukui H, et al. 2020. BMC Cancer. 20:411. PubMed
  143. Yang BH, et al. 2020. Cell Reports. 27(12):3629-3645.e6.. PubMed
  144. Blagih J, et al. 2020. Cell Rep. 30:481. PubMed
  145. Fu S, et al. 2020. Nat Commun. 0.7625. PubMed
  146. Nakamura Y, et al. 2015. Infect Immun . 83:671. PubMed
  147. Zhang Q, et al. 2021. Front Cell Dev Biol. 9:655552. PubMed
  148. Zhong MC, et al. 2021. J Exp Med. 218:. PubMed
  149. Rive CM, et al. 2022. Mol Ther Methods Clin Dev. 26:4. PubMed
  150. Wang Y, et al. 2021. Nat Commun. 12:4964. PubMed
  151. Qi J, et al. 2021. Nat Commun. 12:4755. PubMed
  152. Ben-Yehuda H, et al. 2021. Mol Neurodegener. 16:39. PubMed
  153. Li X, et al. 2021. Cell Death Dis. 12:314. PubMed
  154. Bi CS, et al. 2020. Cell Prolif. 53:e12827. PubMed
  155. Cabrera-Perez C, et al. 2015. J Immunol . 194:1609-20. PubMed
  156. Zhao X, et al. 2022. iScience. 25:104690. PubMed
  157. Xia Y, et al. 2018. Cell. 175:1059. PubMed
  158. Oliveira AC et al. 2017. eLife. 6 pii: e30883. PubMed
  159. Zhang H, et al. 2009. Invest Ophthalmol Vis Sci. 50:2653. PubMed
  160. Daneshmandi S, et al. 2021. Cell Reports. 34(10):108831. PubMed
  161. Zhang Q, et al. 2022. Commun Biol. 5:544. PubMed
  162. Chen S, et al. 2022. iScience. 25:105176. PubMed
  163. Georgiadou A, et al. 2022. Elife. 11:. PubMed
  164. Chen C, et al. 2020. Cell Rep. 2136:30. PubMed
  165. Sanders K, et al. 2015. Cancer Immunol Res. 3: 891-901. PubMed
  166. McCauley ME, et al. 2020. Nature. 585(7823):96-101. PubMed
  167. Liu Y, et al. 2019. Sci Rep. 9:18970. PubMed
  168. Wang J, et al. 2019. Aging (Albany NY). 11:3463. PubMed
  169. Xu Y, et al. 2021. iScience. 24:103445. PubMed
  170. Pantelidou C, et al. 2022. NPJ Breast Cancer. 8:102. PubMed
  171. Deliyannis G, et al. 2021. JCI Insight. 6:. PubMed
  172. Le QV, et al. 2022. Bioact Mater. 15:160. PubMed
  173. Gaya M et al. 2018. Cell. 172(3):517-533 . PubMed
  174. Ireland L, et al. 2020. Front Immunol. 11:297. PubMed
  175. Mahlios J, Zhuang Y 2011. Mol Immunol. 49:227. PubMed
  176. Xu Y, et al. 2016. Nat Commun. 7:12073. PubMed
  177. Klose R, et al. 2016. Nat Commun. 7:12528. PubMed
  178. Zheng DW, et al. 2020. Nat Commun. 3.865972222. PubMed
  179. Rodríguez L, et al. 2021. Biomolecules. 11: . PubMed
  180. Li H, et al. 2022. iScience. 25:104481. PubMed
  181. Chen YL, et al. 2022. Front Neurosci. 16:876582. PubMed
  182. Endo-Umeda K, et al. 2021. Sci Rep. 11:22595. PubMed
  183. Wang J, et al. 2021. Am J Cancer Res. 11:2005. PubMed
  184. Wang F, et al. 2021. Neoplasia. 23:281. PubMed
  185. Gao P, et al. 2021. Nat Commun. 1194:12. PubMed
  186. Yomogida K, et al. 2013. Biochem Biophys Res Commun. 434:263. PubMed
  187. Ajith A, et al. 2019. FASEB J. 33:5220. PubMed
  188. Hidalgo San Jose L, et al. 2020. Cell Rep. 30:69. PubMed
  189. Yeon S, et al. 2017. Sci Rep. 10.1038/s41598-017-11492-7. PubMed
  190. Petty AJ, et al. 2021. JCI Insight. 6:. PubMed
  191. Gawish R, et al. 2022. Elife. 11:. PubMed
  192. Mesin L, et al. 2020. Cell. 180(1):92-106.e11.. PubMed
  193. Crowe J, et al. 2020. PLoS Pathog. 16:e1008391. PubMed
  194. Pflügler S, et al. 2020. Commun Biol. 3:252. PubMed
  195. Rudd CE, et al. 2020. Cell Reports. 30(7):2075-2082. PubMed
  196. Kong IY, et al. 2020. Cell Rep. 33:108290. PubMed
  197. Fu W, et al. 2020. J Immunol Res. 8820355:2020. PubMed
  198. Hu Y, et al. 2021. J Nanobiotechnology. 19:416. PubMed
  199. Cao Y, et al. 2022. Small. 18:e2203466. PubMed
  200. Xu Z, et al. 2022. Cell Death Dis. 13:502. PubMed
  201. Wang Y, et al. 2022. Nat Cell Biol. 24:230. PubMed
  202. Okubo A, et al. 2021. Int J Mol Sci. 23:. PubMed
  203. Lee S, et al. 2021. Autophagy. 18:1062. PubMed
  204. Lal JC, et al. 2021. Breast Cancer Res. 23:83. PubMed
  205. Song X, et al. 2022. Transl Oncol. 15:101306. PubMed
  206. Xie Z, et al. 2020. Light Sci Appl. 9:161. PubMed
  207. Du Z, et al. 2020. J Allergy Clin Immunol. . PubMed
  208. Sun J, et al. 2012. Arterioscler Thromb Vasc Biol. 32:15:00. PubMed
  209. Zveik O, et al. 2022. Glia. 70:1191. PubMed
  210. Yue Y, et al. 2022. Nat Biomed Eng. 6:898. PubMed
  211. Zhou H, et al. 2022. EMBO Rep. 23:e53791. PubMed
  212. Grebinoski S, et al. 2022. Nat Immunol. 23:868. PubMed
  213. Merana GR, et al. 2022. Cell Rep. 39:110891. PubMed
  214. Guo X, et al. 2022. Invest Ophthalmol Vis Sci. 63:12. PubMed
  215. Tessaro FHG, et al. 2022. Cell Rep. 39:110977. PubMed
  216. Shen CY, et al. 2022. Pharmaceutics. 14: . PubMed
  217. Millar FR, et al. 2022. Cell Rep. 41:111596. PubMed
  218. Zhu J, et al. 2022. Nat Commun. 13:7466. PubMed
  219. Shi C, et al. 2023. Nat Nanotechnol. 18:86. PubMed
  220. Yu J, et al. 2022. Nat Commun. 13:7903. PubMed
  221. Zhao X, et al. 2022. STAR Protoc. 3:101859. PubMed
  222. Choi H, et al. 2023. J Nanobiotechnology. 21:5. PubMed
  223. Wang L, et al. 2022. Nutrients. 15: . PubMed
  224. Glaubitz J, et al. 2023. Gut. :. PubMed
  225. Zhao M, et al. 2023. J Nanobiotechnology. 21:50. PubMed
  226. Wang L, et al. 2023. Oxid Med Cell Longev. 2023:6480848. PubMed
  227. Kodali S, et al. 2022. J Immunol. 208:1085. PubMed
  228. McCafferty S, et al. 2022. Mol Ther. 30:2968. PubMed
  229. Puth S, et al. 2022. Biomaterials. 286:121542. PubMed
  230. Lin J, et al. 2022. Adv Sci (Weinh). 9:e2202633. PubMed
  231. Zhao Q, et al. 2023. Signal Transduct Target Ther. 8:40. PubMed
  232. Wang F, et al. 2023. Int J Mol Sci. 24:. PubMed
  233. Wang JX, et al. 2023. JCI Insight. 8:. PubMed
  234. Tan X, et al. 2023. Adv Sci (Weinh). 10:e2206768. PubMed
  235. Fu S, et al. 2023. Nat Commun. 14:2248. PubMed
  236. Kaltenbach L, et al. 2023. Nat Immunol. 24:915. PubMed
  237. Wu N, et al. 2023. Front Bioeng Biotechnol. 11:1173381. PubMed
  238. Ji Y, et al. 2023. Nat Cell Biol. 25:726. PubMed
  239. Guo X, et al. 2023. Mol Immunol. 160:32. PubMed
  240. Kawai H, et al. 2021. Asian Pac J Allergy Immunol. :. PubMed
  241. Tan L, et al. 2022. Aging Dis. 13:1562. PubMed
  242. Palacios-Arreola M, et al. 2017. Sci Rep. 10.1038/s41598-017-10135-1. PubMed
  243. Man SM et al. 2016. Cell. 167(2):382-396 . PubMed
  244. Jiang W, et al. 2017. Sci Rep. 7:6501. PubMed
  245. Xu X, et al. 2020. Chin Med. 15:33. PubMed
  246. Kisielow J, et al. 2019. Nat Immunol. 1.286111111. PubMed
  247. Ajith A, et al. 2021. Front Immunol. 12:687715. PubMed
  248. Garo LP, et al. 2021. Nat Commun. 12:2419. PubMed
  249. Apte SH, et al. 2020. Clin Transl Immunology. 9:e1209. PubMed
  250. Friess MC, et al. 2022. Cell Rep. 38:110334. PubMed
  251. Xiang G, et al. 2022. Cell Death Dis. 13:451. PubMed
  252. Shibata K, et al. 2022. Nat Commun. 13:6948. PubMed
  253. Feola S, et al. 2022. Front Immunol. 13:826164. PubMed
  254. Zhao X, et al. 2022. Front Mol Biosci. 9:786864. PubMed
  255. Qian Y, et al. 2021. Cell Reports. 36(8):109602. PubMed
  256. Chappaz S, et al. 2021. Cell Reports. 36(3):109430. PubMed
  257. Han X, et al. 2017. Int J Mol Sci. 10.3390/ijms18050942. PubMed
  258. Willinger T, et al. 2014. J Exp Med. 211:685. PubMed
  259. Bauer KM, et al. 2022. JCI Insight. 7:. PubMed
  260. Misumi I et al. 2019. Cell Rep. 27(5):1387-1396 . PubMed
  261. Du Q, et al. 2019. Front Microbiol. 10:2050. PubMed
  262. Zhang L, et al. 2020. Front Oncol. 1.243055556. PubMed
  263. Zhang J, et al. 2021. MedComm (Beijing). 2:256. PubMed
  264. Jiang W, et al. 2021. Oncol Lett. 22:625. PubMed
  265. Greenberg J, et al. 2022. JCI Insight. Online ahead of print. PubMed
  266. Tan X, et al. 2021. Front Oncol. 11:768222. PubMed
  267. Ma C, et al. 2021. Signal Transduct Target Ther. 6:353. PubMed
  268. Fu Y, et al. 2020. Mol Ther. 1214:28. PubMed
  269. Haque M, et al. 2021. STAR Protoc. 2:100264. PubMed
  270. Hao B, et al. 2015. J Exp Med. 212:809. PubMed
  271. Sun CC, et al. 2020. Genome Med. 0.553472222. PubMed
  272. Leech JM, et al. 2020. Cell Host & Microbe. 26(6):795-809.e5.. PubMed
  273. Isoda T et al. 2017. Cell. 171(1):103-119 . PubMed
  274. Glaubitz J, et al. 2022. Nat Commun. 13:4502. PubMed
  275. Liang Z, et al. 2021. J Cell Physiol. 236:4725. PubMed
  276. Chen S et al. 2018. Cell reports. 25(7):1729-1740 . PubMed
  277. Pérez‐Mazliah D et al. 2017. EBioMedicine. 24:216-230 . PubMed
  278. Yuan X, et al. 2019. JCI Insight. 4:e124317. PubMed
  279. Tsuchiya N, et al. 2020. Cell Reports. 29(1):162-175.e9.. PubMed
  280. Guo H, et al. 2022. PLoS Pathog. 18:e1010857. PubMed
  281. Khan IM, et al. 2021. Immunohorizons. 5:703. PubMed
  282. Antunes KH, et al. 2022. Front Immunol. 13:867022. PubMed
  283. Li Y, et al. 2022. Clin Transl Immunology. 11:e1362. PubMed
  284. Li H, et al. 2021. Nat Commun. 12:2773. PubMed
  285. Zhang Z, et al. 2021. Oncoimmunology. 10:1912472. PubMed
  286. Mitchell JE, et al. 2021. Cell Reports. 35(2):108966. PubMed
  287. Han C, et al. 2021. Cell Reports. 34(6):108706. PubMed
  288. Perner C, et al. 2020. Immunity. 53(5):1063-1077.e7. PubMed
  289. Sato K, et al. 2015. PLoS One. 10: 0138291. PubMed
  290. Liu J, et al. 2012. PLoS One. 7:e44044. PubMed
  291. Lercher A, et al. 2019. Immunity. 51:1074. PubMed
  292. He W et al. 2018. Immunity. 49(6):1175-1190 . PubMed
  293. Hillel–Karniel C, et al. 2020. Cell Reports. 30(3):807-819.e4.. PubMed
  294. Collin R, et al. 2014. J Immunol. 193:3503. PubMed
  295. Karki R, et al. 2020. JCI Insight. 5:00. PubMed
  296. Paiva RA, et al. 2021. Cell Reports. 35(2):108967. PubMed
  297. Pereira JL, et al. 2021. Transl Oncol. 14:101125. PubMed
  298. Yang L, et al. 2021. Cell Death Differ. 28:2616. PubMed
  299. Pervaiz N, et al. 2021. Pigment Cell Melanoma Res. 34:918. PubMed
  300. Sodji QH, et al. 2022. Cancer Res Commun. 2:725. PubMed
  301. Li J, et al. 2021. Cell Commun Signal. 19:89. PubMed
  302. Lv F, et al. 2022. iScience. 25:103639. PubMed
  303. Mehta AK, et al. 2021. Nat Cancer. 2:66. PubMed
  304. Liu D et al. 2019. Immunity. 51(1):64-76 . PubMed
  305. Fatkhullina AR et al. 2018. Immunity. 49(5):943-957 . PubMed
  306. Akazawa S, et al. 2021. Diabetologia. 64:878. PubMed
  307. Jie X, et al. 2022. J Immunother Cancer. 10:. PubMed
  308. Yang H, et al. 2022. Nutrients. 14:. PubMed
  309. Hönes J, et al. 2017. Sci Rep. . 10.1038/s41598-017-15866-9. PubMed
  310. Lee JS et al. 2018. Cell. 174(6):1559-1570 . PubMed
  311. Niemann J, et al. 2019. Nat Commun. 10:3236. PubMed
  312. Schadt L, et al. 2020. Cell Reports. 29(5):1236-1248.e7.. PubMed
  313. Aebischer D, et al. 2014. PLoS One. 9:99297. PubMed
  314. Xie Z, et al. 2020. Light Sci Appl. 0.486805556. PubMed
  315. Huang YL, et al. 2021. Commun Biol. 4:229. PubMed
  316. Ren Y, et al. 2022. J Immunother Cancer. 10:. PubMed
  317. Harnett MM, et al. 2022. Front Immunol. 13:953053. PubMed
  318. Shen X, et al. 2021. Front Immunol. 12:710750. PubMed
  319. Zuo W, et al. 2022. Cell Death Discov. 8:257. PubMed
  320. Zeng Q, et al. 2022. Front Immunol. 13:740805. PubMed
  321. Zuo S, et al. 2021. J Immunother Cancer. 9:. PubMed
  322. Chen G, et al. 2021. Sci Adv. 7:eabg5686. PubMed
  323. Yang C, et al. 2013. Proc Natl Acad Sci U S A. 111:109. PubMed
  324. Mirando AC, et al. 2020. Oncoimmunology. 9:1760685. PubMed
  325. Cheng Y, et al. 2020. PLoS Pathog. 16:e1008569. PubMed
  326. Parhi L, et al. 2020. Nat Commun. 2.721527778. PubMed
  327. Bai C, et al. 2020. Mol Ther Oncolytics. 17:9. PubMed
  328. Jing Y, et al. 2020. Sci Adv. 6:eaax9455. PubMed
  329. Dmitrieva‐Posocco O et al. 2019. Immunity. 50(1):166-180 . PubMed
  330. Li W, et al. 2019. Nat Commun. 10:3349. PubMed
  331. Palazon A, et al. 2017. Cancer Cell. . 10.1016/j.ccell.2017.10.003. PubMed
  332. Wu H, et al. 2021. Cell Death Discov. 7:225. PubMed
  333. Colombo M, et al. 2022. iScience. 25:105042. PubMed
  334. Ren W, et al. 2018. Mucosal Immunol. 12:531. PubMed
  335. Cai Y, et al. 2019. Cell Rep. 27:3034. PubMed
  336. Matsuo K, et al. 2018. J Immunol. 200:800. PubMed
  337. Du J, et al. 2018. AMB Express. 8:158. PubMed
  338. Guldner IH, et al. 2020. Cell. 183(5):1234-1248.e25. PubMed
  339. Trefzer A, et al. 2021. Cell Reports. 34(6):108748. PubMed
  340. Kruta M, et al. 2021. Cell Stem Cell. :. PubMed
  341. Liu W, et al. 2021. Cell Death Discov. 7:136. PubMed
  342. Huang Z, et al. 2021. Nat Commun. 12:145. PubMed
  343. Cho K, et al. 2021. iScience. 24:103117. PubMed
  344. Andrade ACDSP, et al. 2021. J Virol. 95:e0127621. PubMed
  345. Ding P, et al. 2022. Bone Res. 10:42. PubMed
  346. Daneshmandi S, et al. 2021. Elife. 10:. PubMed
  347. Liyanage S, et al. 2016. Exp Eye Res. 151:160-70. PubMed
  348. Guo H, et al. 2014. J Leukoc Biol. 96:419. PubMed
  349. Tomay F, et al. 2019. J Transl Med. 17:237. PubMed
  350. Tsukui H, et al. 2020. BMC Cancer. 20:411. PubMed
  351. Yang BH, et al. 2020. Cell Reports. 27(12):3629-3645.e6.. PubMed
  352. Blagih J, et al. 2020. Cell Rep. 30:481. PubMed
  353. Fu S, et al. 2020. Nat Commun. 0.7625. PubMed
  354. Nakamura Y, et al. 2015. Infect Immun . 83:671. PubMed
  355. Zhang Q, et al. 2021. Front Cell Dev Biol. 9:655552. PubMed
  356. Zhong MC, et al. 2021. J Exp Med. 218:. PubMed
  357. Rive CM, et al. 2022. Mol Ther Methods Clin Dev. 26:4. PubMed
  358. Wang Y, et al. 2021. Nat Commun. 12:4964. PubMed
  359. Qi J, et al. 2021. Nat Commun. 12:4755. PubMed
  360. Ben-Yehuda H, et al. 2021. Mol Neurodegener. 16:39. PubMed
  361. Li X, et al. 2021. Cell Death Dis. 12:314. PubMed
  362. Bi CS, et al. 2020. Cell Prolif. 53:e12827. PubMed
  363. Cabrera-Perez C, et al. 2015. J Immunol . 194:1609-20. PubMed
  364. Zhao X, et al. 2022. iScience. 25:104690. PubMed
  365. Xia Y, et al. 2018. Cell. 175:1059. PubMed
  366. Oliveira AC et al. 2017. eLife. 6 pii: e30883. PubMed
  367. Zhang H, et al. 2009. Invest Ophthalmol Vis Sci. 50:2653. PubMed
  368. Daneshmandi S, et al. 2021. Cell Reports. 34(10):108831. PubMed
  369. Zhang Q, et al. 2022. Commun Biol. 5:544. PubMed
  370. Chen S, et al. 2022. iScience. 25:105176. PubMed
  371. Georgiadou A, et al. 2022. Elife. 11:. PubMed
  372. Chen C, et al. 2020. Cell Rep. 2136:30. PubMed
  373. Sanders K, et al. 2015. Cancer Immunol Res. 3: 891-901. PubMed
  374. McCauley ME, et al. 2020. Nature. 585(7823):96-101. PubMed
  375. Liu Y, et al. 2019. Sci Rep. 9:18970. PubMed
  376. Wang J, et al. 2019. Aging (Albany NY). 11:3463. PubMed
  377. Xu Y, et al. 2021. iScience. 24:103445. PubMed
  378. Pantelidou C, et al. 2022. NPJ Breast Cancer. 8:102. PubMed
  379. Deliyannis G, et al. 2021. JCI Insight. 6:. PubMed
  380. Le QV, et al. 2022. Bioact Mater. 15:160. PubMed
  381. Gaya M et al. 2018. Cell. 172(3):517-533 . PubMed
  382. Ireland L, et al. 2020. Front Immunol. 11:297. PubMed
  383. Mahlios J, Zhuang Y 2011. Mol Immunol. 49:227. PubMed
  384. Xu Y, et al. 2016. Nat Commun. 7:12073. PubMed
  385. Klose R, et al. 2016. Nat Commun. 7:12528. PubMed
  386. Zheng DW, et al. 2020. Nat Commun. 3.865972222. PubMed
  387. Rodríguez L, et al. 2021. Biomolecules. 11: . PubMed
  388. Li H, et al. 2022. iScience. 25:104481. PubMed
  389. Chen YL, et al. 2022. Front Neurosci. 16:876582. PubMed
  390. Endo-Umeda K, et al. 2021. Sci Rep. 11:22595. PubMed
  391. Wang J, et al. 2021. Am J Cancer Res. 11:2005. PubMed
  392. Wang F, et al. 2021. Neoplasia. 23:281. PubMed
  393. Gao P, et al. 2021. Nat Commun. 1194:12. PubMed
  394. Yomogida K, et al. 2013. Biochem Biophys Res Commun. 434:263. PubMed
  395. Ajith A, et al. 2019. FASEB J. 33:5220. PubMed
  396. Hidalgo San Jose L, et al. 2020. Cell Rep. 30:69. PubMed
  397. Yeon S, et al. 2017. Sci Rep. 10.1038/s41598-017-11492-7. PubMed
  398. Petty AJ, et al. 2021. JCI Insight. 6:. PubMed
  399. Gawish R, et al. 2022. Elife. 11:. PubMed
  400. Mesin L, et al. 2020. Cell. 180(1):92-106.e11.. PubMed
  401. Crowe J, et al. 2020. PLoS Pathog. 16:e1008391. PubMed
  402. Pflügler S, et al. 2020. Commun Biol. 3:252. PubMed
  403. Rudd CE, et al. 2020. Cell Reports. 30(7):2075-2082. PubMed
  404. Kong IY, et al. 2020. Cell Rep. 33:108290. PubMed
  405. Fu W, et al. 2020. J Immunol Res. 8820355:2020. PubMed
  406. Hu Y, et al. 2021. J Nanobiotechnology. 19:416. PubMed
  407. Cao Y, et al. 2022. Small. 18:e2203466. PubMed
  408. Xu Z, et al. 2022. Cell Death Dis. 13:502. PubMed
  409. Wang Y, et al. 2022. Nat Cell Biol. 24:230. PubMed
  410. Okubo A, et al. 2021. Int J Mol Sci. 23:. PubMed
  411. Lee S, et al. 2021. Autophagy. 18:1062. PubMed
  412. Lal JC, et al. 2021. Breast Cancer Res. 23:83. PubMed
  413. Song X, et al. 2022. Transl Oncol. 15:101306. PubMed
  414. Xie Z, et al. 2020. Light Sci Appl. 9:161. PubMed
  415. Du Z, et al. 2020. J Allergy Clin Immunol. . PubMed
  416. Sun J, et al. 2012. Arterioscler Thromb Vasc Biol. 32:15:00. PubMed
RRID
AB_312692 (BioLegend Cat. No. 100407)
AB_312693 (BioLegend Cat. No. 100408)

Antigen Details

Structure
Ig superfamily, 55 kD
Distribution

Majority of thymocytes, T cell subset

Function
TCR co-receptor, T cell activation
Ligand/Receptor
MHC class II molecule
Cell Type
Dendritic cells, T cells, Thymocytes, Tregs
Biology Area
Immunology
Molecular Family
CD Molecules
Antigen References

1. Barclay A, et al. 1997. The Leukocyte Antigen FactsBook Academic Press.
2. Bierer BE, et al. 1989. Annu. Rev. Immunol. 7:579.
3. Janeway CA. 1992. Annu. Rev. Immunol. 10:645.

Gene ID
12504 View all products for this Gene ID
UniProt
View information about CD4 on UniProt.org

Related FAQs

I am unable to see expression of T cell markers such as CD3 and CD4 post activation.
TCR-CD3 complexes on the T-lymphocyte surface are rapidly downregulated upon activation with peptide-MHC complex, superantigen or cross-linking with anti-TCR or anti-CD3 antibodies. PMA/Ionomycin treatment has been shown to downregulate surface CD4 expression. Receptor downregulation is a common biological phenomenon and so make sure that your stimulation treatment is not causing it in your sample type.
What type of PE do you use in your conjugates?
We use R-PE in our conjugates.

Other Formats

View All CD4 Reagents Request Custom Conjugation
Description Clone Applications
APC/Cyanine7 anti-mouse CD4 GK1.5 FC
Brilliant Violet 711™ anti-mouse CD4 GK1.5 FC
Brilliant Violet 510™ anti-mouse CD4 GK1.5 FC
Brilliant Violet 605™ anti-mouse CD4 GK1.5 FC
Brilliant Violet 785™ anti-mouse CD4 GK1.5 FC
PE/Dazzle™ 594 anti-mouse CD4 GK1.5 FC
APC/Fire™ 750 anti-mouse CD4 GK1.5 FC
GoInVivo™ Purified anti-mouse CD4 GK1.5 FC
Brilliant Violet 750™ anti-mouse CD4 GK1.5 FC
Brilliant Violet 650™ anti-mouse CD4 GK1.5 FC
Spark Blue™ 550 anti-mouse CD4 GK1.5 FC
Spark NIR™ 685 anti-mouse CD4 GK1.5 FC
KIRAVIA Blue 520™ anti-mouse CD4 GK1.5 FC
PE/Fire™ 640 anti-mouse CD4 GK1.5 FC
APC/Fire™ 810 anti-mouse CD4 GK1.5 FC
PE/Fire™ 700 anti-mouse CD4 GK1.5 FC
APC anti-mouse CD4 GK1.5 FC
Biotin anti-mouse CD4 GK1.5 FC,IHC-F,ICC
FITC anti-mouse CD4 GK1.5 FC
PE anti-mouse CD4 GK1.5 FC
PE/Cyanine5 anti-mouse CD4 GK1.5 FC
Purified anti-mouse CD4 GK1.5 FC,IHC-F,ICC,IP,Costim,Block,Depletion
Alexa Fluor® 647 anti-mouse CD4 GK1.5 FC,IHC-F
Alexa Fluor® 488 anti-mouse CD4 GK1.5 FC,IHC-F
Pacific Blue™ anti-mouse CD4 GK1.5 FC
Alexa Fluor® 700 anti-mouse CD4 GK1.5 FC
PerCP anti-mouse CD4 GK1.5 FC
PerCP/Cyanine5.5 anti-mouse CD4 GK1.5 FC
Brilliant Violet 421™ anti-mouse CD4 GK1.5 FC,ICC,IHC-F
Ultra-LEAF™ Purified anti-mouse CD4 GK1.5 FC,Block,Costim,Depletion,IHC,IP
Alexa Fluor® 594 anti-mouse CD4 GK1.5 IHC-F,FC,SB
Spark Violet™ 538 anti-mouse CD4 GK1.5 FC
Spark YG™ 593 anti-mouse CD4 GK1.5 FC
Spark Blue™ 574 anti-mouse CD4 Antibody GK1.5 FC
Spark UV™ 387 anti-mouse CD4 GK1.5 FC
Spark Blue™ 515 anti-mouse CD4 GK1.5 FC
Spark PLUS UV395™ anti-mouse CD4 GK1.5 FC
Spark Red™ 718 anti-mouse CD4 (Flexi-Fluor™) GK1.5 FC
PerCP/Fire™ 806 anti-mouse CD4 Antibody GK1.5 FC
PerCP/Fire™ 780 anti-mouse CD4 Antibody GK1.5 FC
Spark YG™ 581 anti-mouse CD4 (Flexi-Fluor™) GK1.5 FC
StarBright UltraViolet 795 anti-mouse CD4 GK1.5 FC
Spark PLUS V475™ anti-mouse CD4 GK1.5 FC
Spark PLUS B488™ anti-mouse CD4 GK1.5 FC
Go To Top Version: 1    Revision Date: 11-30-2012

For Research Use Only. Not for diagnostic or therapeutic use.

 

This product is supplied subject to the terms and conditions, including the limited license, located at www.biolegend.com/terms) ("Terms") and may be used only as provided in the Terms. Without limiting the foregoing, BioLegend products may not be used for any Commercial Purpose as defined in the Terms, resold in any form, used in manufacturing, or reverse engineered, sequenced, or otherwise studied or used to learn its design or composition without express written approval of BioLegend. Regardless of the information given in this document, user is solely responsible for determining any license requirements necessary for user’s intended use and assumes all risk and liability arising from use of the product. BioLegend is not responsible for patent infringement or any other risks or liabilities whatsoever resulting from the use of its products.

 

BioLegend, the BioLegend logo, and all other trademarks are property of BioLegend, Inc. or their respective owners, and all rights are reserved.

 

8999 BioLegend Way, San Diego, CA 92121 www.biolegend.com
Toll-Free Phone: 1-877-Bio-Legend (246-5343) Phone: (858) 768-5800 Fax: (877) 455-9587

This data display is provided for general comparisons between formats.
Your actual data may vary due to variations in samples, target cells, instruments and their settings, staining conditions, and other factors.
If you need assistance with selecting the best format contact our expert technical support team.

Pricing & Availability
Clone
GK1.5 (See other available formats)
Regulatory Status
RUO
Other Names
L3T4, T4
Isotype
Rat IgG2b, κ
Ave. Rating
Submit a Review
Product Citations
publications
1_GK1dot5_PE_021706
C57BL/6 mouse splenocytes were stained with CD4 (clone GK1.5) PE (filled histogram) or rat IgG2b, κ PE isotype control (open histogram).
  • 1_GK1dot5_PE_021706
    C57BL/6 mouse splenocytes were stained with CD4 (clone GK1.5) PE (filled histogram) or rat IgG2b, κ PE isotype control (open histogram).
  • 2_GK15_PE_CD4_Antibody_2_040122
    C57BL/6 mouse splenocytes were stained with CD4 (clone GK1.5) PE (solid line) or rat IgG2b, κ PE isotype control (dashed line).
Compare all formats See PE spectral data
Cat # Size Price Quantity Check Availability Save
100407 50 µg SEK210
Check Availability


Need larger quantities of this item?
Request Bulk Quote
100408 200 µg SEK605
Check Availability


Need larger quantities of this item?
Request Bulk Quote
Description

CD4 is a 55 kD protein also known as L3T4 or T4. It is a member of the Ig superfamily, primarily expressed on most thymocytes, a subset of T cells, and weakly on macrophages and dendritic cells. It acts as a coreceptor with the TCR during T cell activation and thymic differentiation by binding MHC class II and associating with the protein tyrosin kinase, lck.

Product Details
Technical Data Sheet (pdf)

Product Details

Verified Reactivity
Mouse
Antibody Type
Monoclonal
Host Species
Rat
Immunogen
Mouse CTL clone V4
Formulation
Phosphate-buffered solution, pH 7.2, containing 0.09% sodium azide.
Preparation
The antibody was purified by affinity chromatography, and conjugated with PE under optimal conditions.
Concentration
0.2 mg/ml
Storage & Handling
The CD4 antibody solution should be stored undiluted between 2°C and 8°C, and protected from prolonged exposure to light. Do not freeze.
Application

FC - Quality tested
Recommended Usage

Each lot of this antibody is quality control tested by immunofluorescent staining with flow cytometric analysis. For flow cytometric staining, the suggested use of this reagent is ≤0.25 µg per million cells in 100 µl volume. It is recommended that the reagent be titrated for optimal performance for each application.

Excitation Laser
Blue Laser (488 nm)
Green Laser (532 nm)/Yellow-Green Laser (561 nm)
Application Notes

Additional reported applications (for the relevant formats) include: blocking of CD4+ T cell activation1,4,11, thymocyte costimulation3, in vitro and in vivo depletion2,5-8, blocking of egg-sperm cell adhesion1,4, immunohistochemical staining of acetone-fixed frozen sections9,10, immunoprecipitation1,2, and spatial biology (IBEX)12,13. The GK1.5 antibody is able to block CD4 mediated cell adhesion and T cell activation. Binding of GK1.5 antibody to CD4 T cells can be blocked by RM4-5 antibody, but not RM4-4 antibody. For in vivo studies or highly sensitive assays, we recommend Ultra-LEAF™ purified antibody (Cat. No. 100442) with a lower endotoxin limit than standard LEAF™ purified antibodies (Endotoxin < 0.01 EU/µg).

Application References
  1. Dialynas DP, et al. 1983. J. Immunol. 131:2445. (Block, IP)
  2. Dialynas DP, et al. 1983. Immunol. Rev. 74:29. (IP, Deplete)
  3. Wu L, et al. 1991. J. Exp. Med. 174:1617. (Costim)
  4. Godfrey DI, et al. 1994. J. Immunol. 152:4783. (Block)
  5. Gavett SH, et al. 1994. Am. J. Respir. Cell. Mol. Biol. 10:587. (Deplete)
  6. Schuyler M, et al. 1994. Am. J. Respir. Crit. Care Med. 149:1286. (Deplete)
  7. Ghobrial RR, et al. 1989. Clin. Immunol. Immunopathol. 52:486. (Deplete)
  8. Israelski DM, et al. 1989. J. Immunol. 142:954. (Deplete)
  9. Zheng B, et al. 1996. J. Exp. Med. 184:1083. (IHC)
  10. Frei K, et al. 1997. J. Exp. Med. 185:2177. (IHC)
  11. Felix NJ, et al. 2007. Nat. Immunol. 8:388. (Block)
  12. Radtke AJ, et al. 2020. Proc Natl Acad Sci U S A. 117:33455-65. (SB) PubMed
  13. Radtke AJ, et al. 2022. Nat Protoc. 17:378-401. (SB) PubMed
Product Citations
  1. Zveik O, et al. 2022. Glia. 70:1191. PubMed
  2. Yue Y, et al. 2022. Nat Biomed Eng. 6:898. PubMed
  3. Zhou H, et al. 2022. EMBO Rep. 23:e53791. PubMed
  4. Grebinoski S, et al. 2022. Nat Immunol. 23:868. PubMed
  5. Merana GR, et al. 2022. Cell Rep. 39:110891. PubMed
  6. Guo X, et al. 2022. Invest Ophthalmol Vis Sci. 63:12. PubMed
  7. Tessaro FHG, et al. 2022. Cell Rep. 39:110977. PubMed
  8. Shen CY, et al. 2022. Pharmaceutics. 14: . PubMed
  9. Millar FR, et al. 2022. Cell Rep. 41:111596. PubMed
  10. Zhu J, et al. 2022. Nat Commun. 13:7466. PubMed
  11. Shi C, et al. 2023. Nat Nanotechnol. 18:86. PubMed
  12. Yu J, et al. 2022. Nat Commun. 13:7903. PubMed
  13. Zhao X, et al. 2022. STAR Protoc. 3:101859. PubMed
  14. Choi H, et al. 2023. J Nanobiotechnology. 21:5. PubMed
  15. Wang L, et al. 2022. Nutrients. 15: . PubMed
  16. Glaubitz J, et al. 2023. Gut. :. PubMed
  17. Zhao M, et al. 2023. J Nanobiotechnology. 21:50. PubMed
  18. Wang L, et al. 2023. Oxid Med Cell Longev. 2023:6480848. PubMed
  19. Kodali S, et al. 2022. J Immunol. 208:1085. PubMed
  20. McCafferty S, et al. 2022. Mol Ther. 30:2968. PubMed
  21. Puth S, et al. 2022. Biomaterials. 286:121542. PubMed
  22. Lin J, et al. 2022. Adv Sci (Weinh). 9:e2202633. PubMed
  23. Zhao Q, et al. 2023. Signal Transduct Target Ther. 8:40. PubMed
  24. Wang F, et al. 2023. Int J Mol Sci. 24:. PubMed
  25. Wang JX, et al. 2023. JCI Insight. 8:. PubMed
  26. Tan X, et al. 2023. Adv Sci (Weinh). 10:e2206768. PubMed
  27. Fu S, et al. 2023. Nat Commun. 14:2248. PubMed
  28. Kaltenbach L, et al. 2023. Nat Immunol. 24:915. PubMed
  29. Wu N, et al. 2023. Front Bioeng Biotechnol. 11:1173381. PubMed
  30. Ji Y, et al. 2023. Nat Cell Biol. 25:726. PubMed
  31. Guo X, et al. 2023. Mol Immunol. 160:32. PubMed
  32. Kawai H, et al. 2021. Asian Pac J Allergy Immunol. :. PubMed
  33. Tan L, et al. 2022. Aging Dis. 13:1562. PubMed
  34. Palacios-Arreola M, et al. 2017. Sci Rep. 10.1038/s41598-017-10135-1. PubMed
  35. Man SM et al. 2016. Cell. 167(2):382-396 . PubMed
  36. Jiang W, et al. 2017. Sci Rep. 7:6501. PubMed
  37. Xu X, et al. 2020. Chin Med. 15:33. PubMed
  38. Kisielow J, et al. 2019. Nat Immunol. 1.286111111. PubMed
  39. Ajith A, et al. 2021. Front Immunol. 12:687715. PubMed
  40. Garo LP, et al. 2021. Nat Commun. 12:2419. PubMed
  41. Apte SH, et al. 2020. Clin Transl Immunology. 9:e1209. PubMed
  42. Friess MC, et al. 2022. Cell Rep. 38:110334. PubMed
  43. Xiang G, et al. 2022. Cell Death Dis. 13:451. PubMed
  44. Shibata K, et al. 2022. Nat Commun. 13:6948. PubMed
  45. Feola S, et al. 2022. Front Immunol. 13:826164. PubMed
  46. Zhao X, et al. 2022. Front Mol Biosci. 9:786864. PubMed
  47. Qian Y, et al. 2021. Cell Reports. 36(8):109602. PubMed
  48. Chappaz S, et al. 2021. Cell Reports. 36(3):109430. PubMed
  49. Han X, et al. 2017. Int J Mol Sci. 10.3390/ijms18050942. PubMed
  50. Willinger T, et al. 2014. J Exp Med. 211:685. PubMed
  51. Bauer KM, et al. 2022. JCI Insight. 7:. PubMed
  52. Misumi I et al. 2019. Cell Rep. 27(5):1387-1396 . PubMed
  53. Du Q, et al. 2019. Front Microbiol. 10:2050. PubMed
  54. Zhang L, et al. 2020. Front Oncol. 1.243055556. PubMed
  55. Zhang J, et al. 2021. MedComm (Beijing). 2:256. PubMed
  56. Jiang W, et al. 2021. Oncol Lett. 22:625. PubMed
  57. Greenberg J, et al. 2022. JCI Insight. Online ahead of print. PubMed
  58. Tan X, et al. 2021. Front Oncol. 11:768222. PubMed
  59. Ma C, et al. 2021. Signal Transduct Target Ther. 6:353. PubMed
  60. Fu Y, et al. 2020. Mol Ther. 1214:28. PubMed
  61. Haque M, et al. 2021. STAR Protoc. 2:100264. PubMed
  62. Hao B, et al. 2015. J Exp Med. 212:809. PubMed
  63. Sun CC, et al. 2020. Genome Med. 0.553472222. PubMed
  64. Leech JM, et al. 2020. Cell Host & Microbe. 26(6):795-809.e5.. PubMed
  65. Isoda T et al. 2017. Cell. 171(1):103-119 . PubMed
  66. Glaubitz J, et al. 2022. Nat Commun. 13:4502. PubMed
  67. Liang Z, et al. 2021. J Cell Physiol. 236:4725. PubMed
  68. Chen S et al. 2018. Cell reports. 25(7):1729-1740 . PubMed
  69. Pérez‐Mazliah D et al. 2017. EBioMedicine. 24:216-230 . PubMed
  70. Yuan X, et al. 2019. JCI Insight. 4:e124317. PubMed
  71. Tsuchiya N, et al. 2020. Cell Reports. 29(1):162-175.e9.. PubMed
  72. Guo H, et al. 2022. PLoS Pathog. 18:e1010857. PubMed
  73. Khan IM, et al. 2021. Immunohorizons. 5:703. PubMed
  74. Antunes KH, et al. 2022. Front Immunol. 13:867022. PubMed
  75. Li Y, et al. 2022. Clin Transl Immunology. 11:e1362. PubMed
  76. Li H, et al. 2021. Nat Commun. 12:2773. PubMed
  77. Zhang Z, et al. 2021. Oncoimmunology. 10:1912472. PubMed
  78. Mitchell JE, et al. 2021. Cell Reports. 35(2):108966. PubMed
  79. Han C, et al. 2021. Cell Reports. 34(6):108706. PubMed
  80. Perner C, et al. 2020. Immunity. 53(5):1063-1077.e7. PubMed
  81. Sato K, et al. 2015. PLoS One. 10: 0138291. PubMed
  82. Liu J, et al. 2012. PLoS One. 7:e44044. PubMed
  83. Lercher A, et al. 2019. Immunity. 51:1074. PubMed
  84. He W et al. 2018. Immunity. 49(6):1175-1190 . PubMed
  85. Hillel–Karniel C, et al. 2020. Cell Reports. 30(3):807-819.e4.. PubMed
  86. Collin R, et al. 2014. J Immunol. 193:3503. PubMed
  87. Karki R, et al. 2020. JCI Insight. 5:00. PubMed
  88. Paiva RA, et al. 2021. Cell Reports. 35(2):108967. PubMed
  89. Pereira JL, et al. 2021. Transl Oncol. 14:101125. PubMed
  90. Yang L, et al. 2021. Cell Death Differ. 28:2616. PubMed
  91. Pervaiz N, et al. 2021. Pigment Cell Melanoma Res. 34:918. PubMed
  92. Sodji QH, et al. 2022. Cancer Res Commun. 2:725. PubMed
  93. Li J, et al. 2021. Cell Commun Signal. 19:89. PubMed
  94. Lv F, et al. 2022. iScience. 25:103639. PubMed
  95. Mehta AK, et al. 2021. Nat Cancer. 2:66. PubMed
  96. Liu D et al. 2019. Immunity. 51(1):64-76 . PubMed
  97. Fatkhullina AR et al. 2018. Immunity. 49(5):943-957 . PubMed
  98. Akazawa S, et al. 2021. Diabetologia. 64:878. PubMed
  99. Jie X, et al. 2022. J Immunother Cancer. 10:. PubMed
  100. Yang H, et al. 2022. Nutrients. 14:. PubMed
  101. Hönes J, et al. 2017. Sci Rep. . 10.1038/s41598-017-15866-9. PubMed
  102. Lee JS et al. 2018. Cell. 174(6):1559-1570 . PubMed
  103. Niemann J, et al. 2019. Nat Commun. 10:3236. PubMed
  104. Schadt L, et al. 2020. Cell Reports. 29(5):1236-1248.e7.. PubMed
  105. Aebischer D, et al. 2014. PLoS One. 9:99297. PubMed
  106. Xie Z, et al. 2020. Light Sci Appl. 0.486805556. PubMed
  107. Huang YL, et al. 2021. Commun Biol. 4:229. PubMed
  108. Ren Y, et al. 2022. J Immunother Cancer. 10:. PubMed
  109. Harnett MM, et al. 2022. Front Immunol. 13:953053. PubMed
  110. Shen X, et al. 2021. Front Immunol. 12:710750. PubMed
  111. Zuo W, et al. 2022. Cell Death Discov. 8:257. PubMed
  112. Zeng Q, et al. 2022. Front Immunol. 13:740805. PubMed
  113. Zuo S, et al. 2021. J Immunother Cancer. 9:. PubMed
  114. Chen G, et al. 2021. Sci Adv. 7:eabg5686. PubMed
  115. Yang C, et al. 2013. Proc Natl Acad Sci U S A. 111:109. PubMed
  116. Mirando AC, et al. 2020. Oncoimmunology. 9:1760685. PubMed
  117. Cheng Y, et al. 2020. PLoS Pathog. 16:e1008569. PubMed
  118. Parhi L, et al. 2020. Nat Commun. 2.721527778. PubMed
  119. Bai C, et al. 2020. Mol Ther Oncolytics. 17:9. PubMed
  120. Jing Y, et al. 2020. Sci Adv. 6:eaax9455. PubMed
  121. Dmitrieva‐Posocco O et al. 2019. Immunity. 50(1):166-180 . PubMed
  122. Li W, et al. 2019. Nat Commun. 10:3349. PubMed
  123. Palazon A, et al. 2017. Cancer Cell. . 10.1016/j.ccell.2017.10.003. PubMed
  124. Wu H, et al. 2021. Cell Death Discov. 7:225. PubMed
  125. Colombo M, et al. 2022. iScience. 25:105042. PubMed
  126. Ren W, et al. 2018. Mucosal Immunol. 12:531. PubMed
  127. Cai Y, et al. 2019. Cell Rep. 27:3034. PubMed
  128. Matsuo K, et al. 2018. J Immunol. 200:800. PubMed
  129. Du J, et al. 2018. AMB Express. 8:158. PubMed
  130. Guldner IH, et al. 2020. Cell. 183(5):1234-1248.e25. PubMed
  131. Trefzer A, et al. 2021. Cell Reports. 34(6):108748. PubMed
  132. Kruta M, et al. 2021. Cell Stem Cell. :. PubMed
  133. Liu W, et al. 2021. Cell Death Discov. 7:136. PubMed
  134. Huang Z, et al. 2021. Nat Commun. 12:145. PubMed
  135. Cho K, et al. 2021. iScience. 24:103117. PubMed
  136. Andrade ACDSP, et al. 2021. J Virol. 95:e0127621. PubMed
  137. Ding P, et al. 2022. Bone Res. 10:42. PubMed
  138. Daneshmandi S, et al. 2021. Elife. 10:. PubMed
  139. Liyanage S, et al. 2016. Exp Eye Res. 151:160-70. PubMed
  140. Guo H, et al. 2014. J Leukoc Biol. 96:419. PubMed
  141. Tomay F, et al. 2019. J Transl Med. 17:237. PubMed
  142. Tsukui H, et al. 2020. BMC Cancer. 20:411. PubMed
  143. Yang BH, et al. 2020. Cell Reports. 27(12):3629-3645.e6.. PubMed
  144. Blagih J, et al. 2020. Cell Rep. 30:481. PubMed
  145. Fu S, et al. 2020. Nat Commun. 0.7625. PubMed
  146. Nakamura Y, et al. 2015. Infect Immun . 83:671. PubMed
  147. Zhang Q, et al. 2021. Front Cell Dev Biol. 9:655552. PubMed
  148. Zhong MC, et al. 2021. J Exp Med. 218:. PubMed
  149. Rive CM, et al. 2022. Mol Ther Methods Clin Dev. 26:4. PubMed
  150. Wang Y, et al. 2021. Nat Commun. 12:4964. PubMed
  151. Qi J, et al. 2021. Nat Commun. 12:4755. PubMed
  152. Ben-Yehuda H, et al. 2021. Mol Neurodegener. 16:39. PubMed
  153. Li X, et al. 2021. Cell Death Dis. 12:314. PubMed
  154. Bi CS, et al. 2020. Cell Prolif. 53:e12827. PubMed
  155. Cabrera-Perez C, et al. 2015. J Immunol . 194:1609-20. PubMed
  156. Zhao X, et al. 2022. iScience. 25:104690. PubMed
  157. Xia Y, et al. 2018. Cell. 175:1059. PubMed
  158. Oliveira AC et al. 2017. eLife. 6 pii: e30883. PubMed
  159. Zhang H, et al. 2009. Invest Ophthalmol Vis Sci. 50:2653. PubMed
  160. Daneshmandi S, et al. 2021. Cell Reports. 34(10):108831. PubMed
  161. Zhang Q, et al. 2022. Commun Biol. 5:544. PubMed
  162. Chen S, et al. 2022. iScience. 25:105176. PubMed
  163. Georgiadou A, et al. 2022. Elife. 11:. PubMed
  164. Chen C, et al. 2020. Cell Rep. 2136:30. PubMed
  165. Sanders K, et al. 2015. Cancer Immunol Res. 3: 891-901. PubMed
  166. McCauley ME, et al. 2020. Nature. 585(7823):96-101. PubMed
  167. Liu Y, et al. 2019. Sci Rep. 9:18970. PubMed
  168. Wang J, et al. 2019. Aging (Albany NY). 11:3463. PubMed
  169. Xu Y, et al. 2021. iScience. 24:103445. PubMed
  170. Pantelidou C, et al. 2022. NPJ Breast Cancer. 8:102. PubMed
  171. Deliyannis G, et al. 2021. JCI Insight. 6:. PubMed
  172. Le QV, et al. 2022. Bioact Mater. 15:160. PubMed
  173. Gaya M et al. 2018. Cell. 172(3):517-533 . PubMed
  174. Ireland L, et al. 2020. Front Immunol. 11:297. PubMed
  175. Mahlios J, Zhuang Y 2011. Mol Immunol. 49:227. PubMed
  176. Xu Y, et al. 2016. Nat Commun. 7:12073. PubMed
  177. Klose R, et al. 2016. Nat Commun. 7:12528. PubMed
  178. Zheng DW, et al. 2020. Nat Commun. 3.865972222. PubMed
  179. Rodríguez L, et al. 2021. Biomolecules. 11: . PubMed
  180. Li H, et al. 2022. iScience. 25:104481. PubMed
  181. Chen YL, et al. 2022. Front Neurosci. 16:876582. PubMed
  182. Endo-Umeda K, et al. 2021. Sci Rep. 11:22595. PubMed
  183. Wang J, et al. 2021. Am J Cancer Res. 11:2005. PubMed
  184. Wang F, et al. 2021. Neoplasia. 23:281. PubMed
  185. Gao P, et al. 2021. Nat Commun. 1194:12. PubMed
  186. Yomogida K, et al. 2013. Biochem Biophys Res Commun. 434:263. PubMed
  187. Ajith A, et al. 2019. FASEB J. 33:5220. PubMed
  188. Hidalgo San Jose L, et al. 2020. Cell Rep. 30:69. PubMed
  189. Yeon S, et al. 2017. Sci Rep. 10.1038/s41598-017-11492-7. PubMed
  190. Petty AJ, et al. 2021. JCI Insight. 6:. PubMed
  191. Gawish R, et al. 2022. Elife. 11:. PubMed
  192. Mesin L, et al. 2020. Cell. 180(1):92-106.e11.. PubMed
  193. Crowe J, et al. 2020. PLoS Pathog. 16:e1008391. PubMed
  194. Pflügler S, et al. 2020. Commun Biol. 3:252. PubMed
  195. Rudd CE, et al. 2020. Cell Reports. 30(7):2075-2082. PubMed
  196. Kong IY, et al. 2020. Cell Rep. 33:108290. PubMed
  197. Fu W, et al. 2020. J Immunol Res. 8820355:2020. PubMed
  198. Hu Y, et al. 2021. J Nanobiotechnology. 19:416. PubMed
  199. Cao Y, et al. 2022. Small. 18:e2203466. PubMed
  200. Xu Z, et al. 2022. Cell Death Dis. 13:502. PubMed
  201. Wang Y, et al. 2022. Nat Cell Biol. 24:230. PubMed
  202. Okubo A, et al. 2021. Int J Mol Sci. 23:. PubMed
  203. Lee S, et al. 2021. Autophagy. 18:1062. PubMed
  204. Lal JC, et al. 2021. Breast Cancer Res. 23:83. PubMed
  205. Song X, et al. 2022. Transl Oncol. 15:101306. PubMed
  206. Xie Z, et al. 2020. Light Sci Appl. 9:161. PubMed
  207. Du Z, et al. 2020. J Allergy Clin Immunol. . PubMed
  208. Sun J, et al. 2012. Arterioscler Thromb Vasc Biol. 32:15:00. PubMed
  209. Zveik O, et al. 2022. Glia. 70:1191. PubMed
  210. Yue Y, et al. 2022. Nat Biomed Eng. 6:898. PubMed
  211. Zhou H, et al. 2022. EMBO Rep. 23:e53791. PubMed
  212. Grebinoski S, et al. 2022. Nat Immunol. 23:868. PubMed
  213. Merana GR, et al. 2022. Cell Rep. 39:110891. PubMed
  214. Guo X, et al. 2022. Invest Ophthalmol Vis Sci. 63:12. PubMed
  215. Tessaro FHG, et al. 2022. Cell Rep. 39:110977. PubMed
  216. Shen CY, et al. 2022. Pharmaceutics. 14: . PubMed
  217. Millar FR, et al. 2022. Cell Rep. 41:111596. PubMed
  218. Zhu J, et al. 2022. Nat Commun. 13:7466. PubMed
  219. Shi C, et al. 2023. Nat Nanotechnol. 18:86. PubMed
  220. Yu J, et al. 2022. Nat Commun. 13:7903. PubMed
  221. Zhao X, et al. 2022. STAR Protoc. 3:101859. PubMed
  222. Choi H, et al. 2023. J Nanobiotechnology. 21:5. PubMed
  223. Wang L, et al. 2022. Nutrients. 15: . PubMed
  224. Glaubitz J, et al. 2023. Gut. :. PubMed
  225. Zhao M, et al. 2023. J Nanobiotechnology. 21:50. PubMed
  226. Wang L, et al. 2023. Oxid Med Cell Longev. 2023:6480848. PubMed
  227. Kodali S, et al. 2022. J Immunol. 208:1085. PubMed
  228. McCafferty S, et al. 2022. Mol Ther. 30:2968. PubMed
  229. Puth S, et al. 2022. Biomaterials. 286:121542. PubMed
  230. Lin J, et al. 2022. Adv Sci (Weinh). 9:e2202633. PubMed
  231. Zhao Q, et al. 2023. Signal Transduct Target Ther. 8:40. PubMed
  232. Wang F, et al. 2023. Int J Mol Sci. 24:. PubMed
  233. Wang JX, et al. 2023. JCI Insight. 8:. PubMed
  234. Tan X, et al. 2023. Adv Sci (Weinh). 10:e2206768. PubMed
  235. Fu S, et al. 2023. Nat Commun. 14:2248. PubMed
  236. Kaltenbach L, et al. 2023. Nat Immunol. 24:915. PubMed
  237. Wu N, et al. 2023. Front Bioeng Biotechnol. 11:1173381. PubMed
  238. Ji Y, et al. 2023. Nat Cell Biol. 25:726. PubMed
  239. Guo X, et al. 2023. Mol Immunol. 160:32. PubMed
  240. Kawai H, et al. 2021. Asian Pac J Allergy Immunol. :. PubMed
  241. Tan L, et al. 2022. Aging Dis. 13:1562. PubMed
  242. Palacios-Arreola M, et al. 2017. Sci Rep. 10.1038/s41598-017-10135-1. PubMed
  243. Man SM et al. 2016. Cell. 167(2):382-396 . PubMed
  244. Jiang W, et al. 2017. Sci Rep. 7:6501. PubMed
  245. Xu X, et al. 2020. Chin Med. 15:33. PubMed
  246. Kisielow J, et al. 2019. Nat Immunol. 1.286111111. PubMed
  247. Ajith A, et al. 2021. Front Immunol. 12:687715. PubMed
  248. Garo LP, et al. 2021. Nat Commun. 12:2419. PubMed
  249. Apte SH, et al. 2020. Clin Transl Immunology. 9:e1209. PubMed
  250. Friess MC, et al. 2022. Cell Rep. 38:110334. PubMed
  251. Xiang G, et al. 2022. Cell Death Dis. 13:451. PubMed
  252. Shibata K, et al. 2022. Nat Commun. 13:6948. PubMed
  253. Feola S, et al. 2022. Front Immunol. 13:826164. PubMed
  254. Zhao X, et al. 2022. Front Mol Biosci. 9:786864. PubMed
  255. Qian Y, et al. 2021. Cell Reports. 36(8):109602. PubMed
  256. Chappaz S, et al. 2021. Cell Reports. 36(3):109430. PubMed
  257. Han X, et al. 2017. Int J Mol Sci. 10.3390/ijms18050942. PubMed
  258. Willinger T, et al. 2014. J Exp Med. 211:685. PubMed
  259. Bauer KM, et al. 2022. JCI Insight. 7:. PubMed
  260. Misumi I et al. 2019. Cell Rep. 27(5):1387-1396 . PubMed
  261. Du Q, et al. 2019. Front Microbiol. 10:2050. PubMed
  262. Zhang L, et al. 2020. Front Oncol. 1.243055556. PubMed
  263. Zhang J, et al. 2021. MedComm (Beijing). 2:256. PubMed
  264. Jiang W, et al. 2021. Oncol Lett. 22:625. PubMed
  265. Greenberg J, et al. 2022. JCI Insight. Online ahead of print. PubMed
  266. Tan X, et al. 2021. Front Oncol. 11:768222. PubMed
  267. Ma C, et al. 2021. Signal Transduct Target Ther. 6:353. PubMed
  268. Fu Y, et al. 2020. Mol Ther. 1214:28. PubMed
  269. Haque M, et al. 2021. STAR Protoc. 2:100264. PubMed
  270. Hao B, et al. 2015. J Exp Med. 212:809. PubMed
  271. Sun CC, et al. 2020. Genome Med. 0.553472222. PubMed
  272. Leech JM, et al. 2020. Cell Host & Microbe. 26(6):795-809.e5.. PubMed
  273. Isoda T et al. 2017. Cell. 171(1):103-119 . PubMed
  274. Glaubitz J, et al. 2022. Nat Commun. 13:4502. PubMed
  275. Liang Z, et al. 2021. J Cell Physiol. 236:4725. PubMed
  276. Chen S et al. 2018. Cell reports. 25(7):1729-1740 . PubMed
  277. Pérez‐Mazliah D et al. 2017. EBioMedicine. 24:216-230 . PubMed
  278. Yuan X, et al. 2019. JCI Insight. 4:e124317. PubMed
  279. Tsuchiya N, et al. 2020. Cell Reports. 29(1):162-175.e9.. PubMed
  280. Guo H, et al. 2022. PLoS Pathog. 18:e1010857. PubMed
  281. Khan IM, et al. 2021. Immunohorizons. 5:703. PubMed
  282. Antunes KH, et al. 2022. Front Immunol. 13:867022. PubMed
  283. Li Y, et al. 2022. Clin Transl Immunology. 11:e1362. PubMed
  284. Li H, et al. 2021. Nat Commun. 12:2773. PubMed
  285. Zhang Z, et al. 2021. Oncoimmunology. 10:1912472. PubMed
  286. Mitchell JE, et al. 2021. Cell Reports. 35(2):108966. PubMed
  287. Han C, et al. 2021. Cell Reports. 34(6):108706. PubMed
  288. Perner C, et al. 2020. Immunity. 53(5):1063-1077.e7. PubMed
  289. Sato K, et al. 2015. PLoS One. 10: 0138291. PubMed
  290. Liu J, et al. 2012. PLoS One. 7:e44044. PubMed
  291. Lercher A, et al. 2019. Immunity. 51:1074. PubMed
  292. He W et al. 2018. Immunity. 49(6):1175-1190 . PubMed
  293. Hillel–Karniel C, et al. 2020. Cell Reports. 30(3):807-819.e4.. PubMed
  294. Collin R, et al. 2014. J Immunol. 193:3503. PubMed
  295. Karki R, et al. 2020. JCI Insight. 5:00. PubMed
  296. Paiva RA, et al. 2021. Cell Reports. 35(2):108967. PubMed
  297. Pereira JL, et al. 2021. Transl Oncol. 14:101125. PubMed
  298. Yang L, et al. 2021. Cell Death Differ. 28:2616. PubMed
  299. Pervaiz N, et al. 2021. Pigment Cell Melanoma Res. 34:918. PubMed
  300. Sodji QH, et al. 2022. Cancer Res Commun. 2:725. PubMed
  301. Li J, et al. 2021. Cell Commun Signal. 19:89. PubMed
  302. Lv F, et al. 2022. iScience. 25:103639. PubMed
  303. Mehta AK, et al. 2021. Nat Cancer. 2:66. PubMed
  304. Liu D et al. 2019. Immunity. 51(1):64-76 . PubMed
  305. Fatkhullina AR et al. 2018. Immunity. 49(5):943-957 . PubMed
  306. Akazawa S, et al. 2021. Diabetologia. 64:878. PubMed
  307. Jie X, et al. 2022. J Immunother Cancer. 10:. PubMed
  308. Yang H, et al. 2022. Nutrients. 14:. PubMed
  309. Hönes J, et al. 2017. Sci Rep. . 10.1038/s41598-017-15866-9. PubMed
  310. Lee JS et al. 2018. Cell. 174(6):1559-1570 . PubMed
  311. Niemann J, et al. 2019. Nat Commun. 10:3236. PubMed
  312. Schadt L, et al. 2020. Cell Reports. 29(5):1236-1248.e7.. PubMed
  313. Aebischer D, et al. 2014. PLoS One. 9:99297. PubMed
  314. Xie Z, et al. 2020. Light Sci Appl. 0.486805556. PubMed
  315. Huang YL, et al. 2021. Commun Biol. 4:229. PubMed
  316. Ren Y, et al. 2022. J Immunother Cancer. 10:. PubMed
  317. Harnett MM, et al. 2022. Front Immunol. 13:953053. PubMed
  318. Shen X, et al. 2021. Front Immunol. 12:710750. PubMed
  319. Zuo W, et al. 2022. Cell Death Discov. 8:257. PubMed
  320. Zeng Q, et al. 2022. Front Immunol. 13:740805. PubMed
  321. Zuo S, et al. 2021. J Immunother Cancer. 9:. PubMed
  322. Chen G, et al. 2021. Sci Adv. 7:eabg5686. PubMed
  323. Yang C, et al. 2013. Proc Natl Acad Sci U S A. 111:109. PubMed
  324. Mirando AC, et al. 2020. Oncoimmunology. 9:1760685. PubMed
  325. Cheng Y, et al. 2020. PLoS Pathog. 16:e1008569. PubMed
  326. Parhi L, et al. 2020. Nat Commun. 2.721527778. PubMed
  327. Bai C, et al. 2020. Mol Ther Oncolytics. 17:9. PubMed
  328. Jing Y, et al. 2020. Sci Adv. 6:eaax9455. PubMed
  329. Dmitrieva‐Posocco O et al. 2019. Immunity. 50(1):166-180 . PubMed
  330. Li W, et al. 2019. Nat Commun. 10:3349. PubMed
  331. Palazon A, et al. 2017. Cancer Cell. . 10.1016/j.ccell.2017.10.003. PubMed
  332. Wu H, et al. 2021. Cell Death Discov. 7:225. PubMed
  333. Colombo M, et al. 2022. iScience. 25:105042. PubMed
  334. Ren W, et al. 2018. Mucosal Immunol. 12:531. PubMed
  335. Cai Y, et al. 2019. Cell Rep. 27:3034. PubMed
  336. Matsuo K, et al. 2018. J Immunol. 200:800. PubMed
  337. Du J, et al. 2018. AMB Express. 8:158. PubMed
  338. Guldner IH, et al. 2020. Cell. 183(5):1234-1248.e25. PubMed
  339. Trefzer A, et al. 2021. Cell Reports. 34(6):108748. PubMed
  340. Kruta M, et al. 2021. Cell Stem Cell. :. PubMed
  341. Liu W, et al. 2021. Cell Death Discov. 7:136. PubMed
  342. Huang Z, et al. 2021. Nat Commun. 12:145. PubMed
  343. Cho K, et al. 2021. iScience. 24:103117. PubMed
  344. Andrade ACDSP, et al. 2021. J Virol. 95:e0127621. PubMed
  345. Ding P, et al. 2022. Bone Res. 10:42. PubMed
  346. Daneshmandi S, et al. 2021. Elife. 10:. PubMed
  347. Liyanage S, et al. 2016. Exp Eye Res. 151:160-70. PubMed
  348. Guo H, et al. 2014. J Leukoc Biol. 96:419. PubMed
  349. Tomay F, et al. 2019. J Transl Med. 17:237. PubMed
  350. Tsukui H, et al. 2020. BMC Cancer. 20:411. PubMed
  351. Yang BH, et al. 2020. Cell Reports. 27(12):3629-3645.e6.. PubMed
  352. Blagih J, et al. 2020. Cell Rep. 30:481. PubMed
  353. Fu S, et al. 2020. Nat Commun. 0.7625. PubMed
  354. Nakamura Y, et al. 2015. Infect Immun . 83:671. PubMed
  355. Zhang Q, et al. 2021. Front Cell Dev Biol. 9:655552. PubMed
  356. Zhong MC, et al. 2021. J Exp Med. 218:. PubMed
  357. Rive CM, et al. 2022. Mol Ther Methods Clin Dev. 26:4. PubMed
  358. Wang Y, et al. 2021. Nat Commun. 12:4964. PubMed
  359. Qi J, et al. 2021. Nat Commun. 12:4755. PubMed
  360. Ben-Yehuda H, et al. 2021. Mol Neurodegener. 16:39. PubMed
  361. Li X, et al. 2021. Cell Death Dis. 12:314. PubMed
  362. Bi CS, et al. 2020. Cell Prolif. 53:e12827. PubMed
  363. Cabrera-Perez C, et al. 2015. J Immunol . 194:1609-20. PubMed
  364. Zhao X, et al. 2022. iScience. 25:104690. PubMed
  365. Xia Y, et al. 2018. Cell. 175:1059. PubMed
  366. Oliveira AC et al. 2017. eLife. 6 pii: e30883. PubMed
  367. Zhang H, et al. 2009. Invest Ophthalmol Vis Sci. 50:2653. PubMed
  368. Daneshmandi S, et al. 2021. Cell Reports. 34(10):108831. PubMed
  369. Zhang Q, et al. 2022. Commun Biol. 5:544. PubMed
  370. Chen S, et al. 2022. iScience. 25:105176. PubMed
  371. Georgiadou A, et al. 2022. Elife. 11:. PubMed
  372. Chen C, et al. 2020. Cell Rep. 2136:30. PubMed
  373. Sanders K, et al. 2015. Cancer Immunol Res. 3: 891-901. PubMed
  374. McCauley ME, et al. 2020. Nature. 585(7823):96-101. PubMed
  375. Liu Y, et al. 2019. Sci Rep. 9:18970. PubMed
  376. Wang J, et al. 2019. Aging (Albany NY). 11:3463. PubMed
  377. Xu Y, et al. 2021. iScience. 24:103445. PubMed
  378. Pantelidou C, et al. 2022. NPJ Breast Cancer. 8:102. PubMed
  379. Deliyannis G, et al. 2021. JCI Insight. 6:. PubMed
  380. Le QV, et al. 2022. Bioact Mater. 15:160. PubMed
  381. Gaya M et al. 2018. Cell. 172(3):517-533 . PubMed
  382. Ireland L, et al. 2020. Front Immunol. 11:297. PubMed
  383. Mahlios J, Zhuang Y 2011. Mol Immunol. 49:227. PubMed
  384. Xu Y, et al. 2016. Nat Commun. 7:12073. PubMed
  385. Klose R, et al. 2016. Nat Commun. 7:12528. PubMed
  386. Zheng DW, et al. 2020. Nat Commun. 3.865972222. PubMed
  387. Rodríguez L, et al. 2021. Biomolecules. 11: . PubMed
  388. Li H, et al. 2022. iScience. 25:104481. PubMed
  389. Chen YL, et al. 2022. Front Neurosci. 16:876582. PubMed
  390. Endo-Umeda K, et al. 2021. Sci Rep. 11:22595. PubMed
  391. Wang J, et al. 2021. Am J Cancer Res. 11:2005. PubMed
  392. Wang F, et al. 2021. Neoplasia. 23:281. PubMed
  393. Gao P, et al. 2021. Nat Commun. 1194:12. PubMed
  394. Yomogida K, et al. 2013. Biochem Biophys Res Commun. 434:263. PubMed
  395. Ajith A, et al. 2019. FASEB J. 33:5220. PubMed
  396. Hidalgo San Jose L, et al. 2020. Cell Rep. 30:69. PubMed
  397. Yeon S, et al. 2017. Sci Rep. 10.1038/s41598-017-11492-7. PubMed
  398. Petty AJ, et al. 2021. JCI Insight. 6:. PubMed
  399. Gawish R, et al. 2022. Elife. 11:. PubMed
  400. Mesin L, et al. 2020. Cell. 180(1):92-106.e11.. PubMed
  401. Crowe J, et al. 2020. PLoS Pathog. 16:e1008391. PubMed
  402. Pflügler S, et al. 2020. Commun Biol. 3:252. PubMed
  403. Rudd CE, et al. 2020. Cell Reports. 30(7):2075-2082. PubMed
  404. Kong IY, et al. 2020. Cell Rep. 33:108290. PubMed
  405. Fu W, et al. 2020. J Immunol Res. 8820355:2020. PubMed
  406. Hu Y, et al. 2021. J Nanobiotechnology. 19:416. PubMed
  407. Cao Y, et al. 2022. Small. 18:e2203466. PubMed
  408. Xu Z, et al. 2022. Cell Death Dis. 13:502. PubMed
  409. Wang Y, et al. 2022. Nat Cell Biol. 24:230. PubMed
  410. Okubo A, et al. 2021. Int J Mol Sci. 23:. PubMed
  411. Lee S, et al. 2021. Autophagy. 18:1062. PubMed
  412. Lal JC, et al. 2021. Breast Cancer Res. 23:83. PubMed
  413. Song X, et al. 2022. Transl Oncol. 15:101306. PubMed
  414. Xie Z, et al. 2020. Light Sci Appl. 9:161. PubMed
  415. Du Z, et al. 2020. J Allergy Clin Immunol. . PubMed
  416. Sun J, et al. 2012. Arterioscler Thromb Vasc Biol. 32:15:00. PubMed
RRID
AB_312692 (BioLegend Cat. No. 100407)
AB_312693 (BioLegend Cat. No. 100408)

Antigen Details

Structure
Ig superfamily, 55 kD
Distribution

Majority of thymocytes, T cell subset

Function
TCR co-receptor, T cell activation
Ligand/Receptor
MHC class II molecule
Cell Type
Dendritic cells, T cells, Thymocytes, Tregs
Biology Area
Immunology
Molecular Family
CD Molecules
Antigen References

1. Barclay A, et al. 1997. The Leukocyte Antigen FactsBook Academic Press.
2. Bierer BE, et al. 1989. Annu. Rev. Immunol. 7:579.
3. Janeway CA. 1992. Annu. Rev. Immunol. 10:645.

Gene ID
12504 View all products for this Gene ID
UniProt
View information about CD4 on UniProt.org

Related FAQs

I am unable to see expression of T cell markers such as CD3 and CD4 post activation.
TCR-CD3 complexes on the T-lymphocyte surface are rapidly downregulated upon activation with peptide-MHC complex, superantigen or cross-linking with anti-TCR or anti-CD3 antibodies. PMA/Ionomycin treatment has been shown to downregulate surface CD4 expression. Receptor downregulation is a common biological phenomenon and so make sure that your stimulation treatment is not causing it in your sample type.
What type of PE do you use in your conjugates?
We use R-PE in our conjugates.

Other Formats

View All CD4 Reagents Request Custom Conjugation
Description Clone Applications
APC/Cyanine7 anti-mouse CD4 GK1.5 FC
Brilliant Violet 711™ anti-mouse CD4 GK1.5 FC
Brilliant Violet 510™ anti-mouse CD4 GK1.5 FC
Brilliant Violet 605™ anti-mouse CD4 GK1.5 FC
Brilliant Violet 785™ anti-mouse CD4 GK1.5 FC
PE/Dazzle™ 594 anti-mouse CD4 GK1.5 FC
APC/Fire™ 750 anti-mouse CD4 GK1.5 FC
GoInVivo™ Purified anti-mouse CD4 GK1.5 FC
Brilliant Violet 750™ anti-mouse CD4 GK1.5 FC
Brilliant Violet 650™ anti-mouse CD4 GK1.5 FC
Spark Blue™ 550 anti-mouse CD4 GK1.5 FC
Spark NIR™ 685 anti-mouse CD4 GK1.5 FC
KIRAVIA Blue 520™ anti-mouse CD4 GK1.5 FC
PE/Fire™ 640 anti-mouse CD4 GK1.5 FC
APC/Fire™ 810 anti-mouse CD4 GK1.5 FC
PE/Fire™ 700 anti-mouse CD4 GK1.5 FC
APC anti-mouse CD4 GK1.5 FC
Biotin anti-mouse CD4 GK1.5 FC,IHC-F,ICC
FITC anti-mouse CD4 GK1.5 FC
PE anti-mouse CD4 GK1.5 FC
PE/Cyanine5 anti-mouse CD4 GK1.5 FC
Purified anti-mouse CD4 GK1.5 FC,IHC-F,ICC,IP,Costim,Block,Depletion
Alexa Fluor® 647 anti-mouse CD4 GK1.5 FC,IHC-F
Alexa Fluor® 488 anti-mouse CD4 GK1.5 FC,IHC-F
Pacific Blue™ anti-mouse CD4 GK1.5 FC
Alexa Fluor® 700 anti-mouse CD4 GK1.5 FC
PerCP anti-mouse CD4 GK1.5 FC
PerCP/Cyanine5.5 anti-mouse CD4 GK1.5 FC
Brilliant Violet 421™ anti-mouse CD4 GK1.5 FC,ICC,IHC-F
Ultra-LEAF™ Purified anti-mouse CD4 GK1.5 FC,Block,Costim,Depletion,IHC,IP
Alexa Fluor® 594 anti-mouse CD4 GK1.5 IHC-F,FC,SB
Spark Violet™ 538 anti-mouse CD4 GK1.5 FC
Spark YG™ 593 anti-mouse CD4 GK1.5 FC
Spark Blue™ 574 anti-mouse CD4 Antibody GK1.5 FC
Spark UV™ 387 anti-mouse CD4 GK1.5 FC
Spark Blue™ 515 anti-mouse CD4 GK1.5 FC
Spark PLUS UV395™ anti-mouse CD4 GK1.5 FC
Spark Red™ 718 anti-mouse CD4 (Flexi-Fluor™) GK1.5 FC
PerCP/Fire™ 806 anti-mouse CD4 Antibody GK1.5 FC
PerCP/Fire™ 780 anti-mouse CD4 Antibody GK1.5 FC
Spark YG™ 581 anti-mouse CD4 (Flexi-Fluor™) GK1.5 FC
StarBright UltraViolet 795 anti-mouse CD4 GK1.5 FC
Spark PLUS V475™ anti-mouse CD4 GK1.5 FC
Spark PLUS B488™ anti-mouse CD4 GK1.5 FC
Go To Top Version: 1    Revision Date: 11-30-2012

For Research Use Only. Not for diagnostic or therapeutic use.

 

This product is supplied subject to the terms and conditions, including the limited license, located at www.biolegend.com/terms) ("Terms") and may be used only as provided in the Terms. Without limiting the foregoing, BioLegend products may not be used for any Commercial Purpose as defined in the Terms, resold in any form, used in manufacturing, or reverse engineered, sequenced, or otherwise studied or used to learn its design or composition without express written approval of BioLegend. Regardless of the information given in this document, user is solely responsible for determining any license requirements necessary for user’s intended use and assumes all risk and liability arising from use of the product. BioLegend is not responsible for patent infringement or any other risks or liabilities whatsoever resulting from the use of its products.

 

BioLegend, the BioLegend logo, and all other trademarks are property of BioLegend, Inc. or their respective owners, and all rights are reserved.

 

8999 BioLegend Way, San Diego, CA 92121 www.biolegend.com
Toll-Free Phone: 1-877-Bio-Legend (246-5343) Phone: (858) 768-5800 Fax: (877) 455-9587

This data display is provided for general comparisons between formats.
Your actual data may vary due to variations in samples, target cells, instruments and their settings, staining conditions, and other factors.
If you need assistance with selecting the best format contact our expert technical support team.

ProductsHere
Login / Register
Remember me
Forgot your password? Reset password?
Create an Account